These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8729520)

  • 1. Heterogeneous distribution of thyrotrophin receptor messenger ribonucleic acid (TSH-R mRNA) in papillary thyroid carcinomas detected by in situ hybridization.
    Tanaka K; Inoue H; Miki H; Komaki K; Monden Y
    Clin Endocrinol (Oxf); 1996 Mar; 44(3):259-67. PubMed ID: 8729520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid transcription factor-1 in normal, hyperplastic, and neoplastic follicular thyroid cells examined by immunohistochemistry and nonradioactive in situ hybridization.
    Katoh R; Kawaoi A; Miyagi E; Li X; Suzuki K; Nakamura Y; Kakudo K
    Mod Pathol; 2000 May; 13(5):570-6. PubMed ID: 10824930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas.
    Park HJ; Kim JY; Park KY; Gong G; Hong SJ; Ahn IM
    Thyroid; 2000 Mar; 10(3):211-7. PubMed ID: 10779135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of thyrotropin receptor (TSH-R), thyroglobulin, thyroperoxidase, and calcitonin messenger ribonucleic acids in thyroid carcinomas: evidence of TSH-R gene transcript in medullary histotype.
    Elisei R; Pinchera A; Romei C; Gryczynska M; Pohl V; Maenhaut C; Fugazzola L; Pacini F
    J Clin Endocrinol Metab; 1994 Apr; 78(4):867-71. PubMed ID: 8157713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of thyrotrophin receptor gene in thyroid carcinoma is associated with a good prognosis.
    Shi Y; Zou M; Farid NR
    Clin Endocrinol (Oxf); 1993 Sep; 39(3):269-74. PubMed ID: 8222289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
    McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid detection of specific messenger RNAs in thyroid carcinomas by reverse transcription-PCR with degenerate primers: specific expression of oncofetal fibronectin messenger RNA in papillary carcinoma.
    Takano T; Matsuzuka F; Sumizaki H; Kuma K; Amino N
    Cancer Res; 1997 Sep; 57(17):3792-7. PubMed ID: 9288789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.
    Xu X; Quiros RM; Maxhimer JB; Jiang P; Marcinek R; Ain KB; Platt JL; Shen J; Gattuso P; Prinz RA
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5968-79. PubMed ID: 14676122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical loss of thyroid peroxidase in papillary thyroid carcinoma: strong suppression of peroxidase gene expression.
    Tanaka T; Umeki K; Yamamoto I; Sugiyama S; Noguchi S; Ohtaki S
    J Pathol; 1996 May; 179(1):89-94. PubMed ID: 8691351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of laminin receptor mRNA in human cancer cell lines and colorectal tissues by in situ hybridization.
    Campo E; Monteagudo C; Castronovo V; Claysmith AP; Fernandez PL; Sobel ME
    Am J Pathol; 1992 Nov; 141(5):1073-83. PubMed ID: 1443045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ detection of hTERT mRNA relates to Ki-67 labeling index in papillary thyroid carcinoma.
    Chou SJ; Chen CM; Harn HJ; Chen CJ; Liu YC
    J Surg Res; 2001 Jul; 99(1):75-83. PubMed ID: 11421607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E-cadherin: a differentiation marker in thyroid malignancies.
    Brabant G; Hoang-Vu C; Cetin Y; Dralle H; Scheumann G; Mölne J; Hansson G; Jansson S; Ericson LE; Nilsson M
    Cancer Res; 1993 Oct; 53(20):4987-93. PubMed ID: 8402689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of parathyroid hormone-related peptide in human thyroid tumours.
    Nakashima M; Ohtsuru A; Luo WT; Nakayama T; Enomoto H; Usa T; Kiriyama T; Ito M; Nagataki S; Yamashita S
    J Pathol; 1995 Feb; 175(2):227-36. PubMed ID: 7738719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of thyrotropin receptor and thyroid hormone receptor messenger ribonucleic acid in normal, hyperplastic, and neoplastic human thyroid tissue.
    Brönnegård M; Törring O; Böös J; Sylven C; Marcus C; Wallin G
    J Clin Endocrinol Metab; 1994 Aug; 79(2):384-9. PubMed ID: 8045952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
    Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
    Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between prognostic score and thyrotropin receptor (TSH-R) in papillary thyroid carcinoma: immunohistochemical detection of TSH-R.
    Tanaka K; Inoue H; Miki H; Masuda E; Kitaichi M; Komaki K; Uyama T; Monden Y
    Br J Cancer; 1997; 76(5):594-9. PubMed ID: 9303357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical and in situ hybridization analyses of midkine expression in thyroid papillary carcinoma.
    Kato M; Maeta H; Kato S; Shinozawa T; Terada T
    Mod Pathol; 2000 Oct; 13(10):1060-5. PubMed ID: 11048798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue.
    Fernández PL; Merino MJ; Gómez M; Campo E; Medina T; Castronovo V; Sanjuán X; Cardesa A; Liu FT; Sobel ME
    J Pathol; 1997 Jan; 181(1):80-6. PubMed ID: 9072007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Met protein and urokinase-type plasminogen activator receptor (uPA-R) in papillary carcinoma of the thyroid.
    Zanetti A; Stoppacciaro A; Marzullo A; Ciabatta M; Fazioli F; Prat M; Comoglio PM; Baroni CD; Ruco LP
    J Pathol; 1998 Nov; 186(3):287-91. PubMed ID: 10211118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes.
    Lazar V; Bidart JM; Caillou B; Mahé C; Lacroix L; Filetti S; Schlumberger M
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3228-34. PubMed ID: 10487692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.